A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

This study is testing a new cancer drug to evaluate its safety, how well it's tolerated, and early signs of whether it works. It targets several types of advanced cancers including non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), and other solid tumors that have not responded to standard treatments. **You may be eligible if...** - You are 18 years old or older - You have advanced cancer confirmed by lab tests that has progressed after standard treatments, or no standard treatment is available - You have adequate organ function and overall health - Specific cancer types are being enrolled, including NSCLC, TNBC, and others **You may NOT be eligible if...** - You have untreated brain metastases - You have active autoimmune disease or are on immunosuppressants - You have had certain prior treatments that would interfere with the study drug - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.